Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease
Josef S Smolen(Leiden University Medical Center), Jean‐Yves Reginster(King Saud University), Ronald van Vollenhoven(Amsterdam University Medical Centers), Olivier Bruyère(University of Liège), Pierre Miossec(Université Claude Bernard Lyon 1), Sabine Collaud Basset(TRB Chemedica International (Switzerland)), Peter Tugwell(University of Ottawa), Heidi Mäkinen(Central Finland Health Care District), Maarten Boers(Amsterdam University Medical Centers), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Thierry Thomas(Lyon 1 Université), Cyrus Cooper(University Hospital Southampton NHS Foundation Trust), Tuulikki Sokka‐Isler(University of Eastern Finland), Ferdinand C. Breedveld(Leiden University Medical Center), Tore K Kvien(Diakonhjemmet Hospital), Éric Abadie(Ifremer)
Cited by 30
Related Papers
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
|Arthritis & Rheumatism|1990|9.6k
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2001|4.6k
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
|Osteoporosis International|2012|2.9k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k